A detailed history of Quantitative Investment Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Quantitative Investment Management, LLC holds 2,320 shares of RGEN stock, worth $340,854. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,320
Holding current value
$340,854
% of portfolio
0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$123.41 - $160.92 $286,311 - $373,334
2,320 New
2,320 $333,000
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $605,585 - $967,192
3,775 New
3,775 $706,000
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $204,020 - $271,768
-1,230 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $221,855 - $278,299
1,230 New
1,230 $239,000
Q3 2020

Nov 13, 2020

SELL
$122.51 - $158.27 $1.55 Million - $2.01 Million
-12,673 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$94.33 - $140.48 $1.2 Million - $1.78 Million
12,673 New
12,673 $1.57 Million
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $704,581 - $888,169
-9,542 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $731,394 - $911,356
9,542 New
9,542 $731,000
Q2 2019

Aug 14, 2019

SELL
$54.2 - $85.95 $308,940 - $489,915
-5,700 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$49.45 - $62.8 $281,865 - $357,960
5,700 New
5,700 $336,000
Q4 2018

Feb 12, 2019

SELL
$48.26 - $68.88 $241,300 - $344,400
-5,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$46.8 - $58.97 $234,000 - $294,850
5,000 New
5,000 $277,000
Q4 2017

Feb 14, 2018

SELL
$32.53 - $38.92 $1.51 Million - $1.81 Million
-46,500 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$36.98 - $46.06 $1.72 Million - $2.14 Million
46,500
46,500 $1.78 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Quantitative Investment Management, LLC Portfolio

Follow Quantitative Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.